Chicago-based Cook County Health has unveiled a new logo as part of a brand redesign.

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Vaccines have started to trickle into the Democratic Republic of Congo after a lethal mpox outbreak, but it’s nowhere near ...

UK pharma major GSK (LSE: GSK) today announced positive headline results of MATINEE, the Phase III clinical trial evaluating its asthma drug Nucala (mepolizumab), a monoclonal antibody that targets ...

GLAXOSMITHKLINE (GSK) has confirmed that its manufacturing operations will cease next year as its current contract with a pharmaceutical company has not been extended. GSK has been slowly ...

GLAXOSMITHKLINE (GSK) has confirmed that its manufacturing operations will cease next year as its current contract with a pharmaceutical company has not been extended. GSK has been slowly ...

For example: For all adults aged 60 and older, the societal cost per QALY saved was $196,842 for GSK's Arexvy and $176,557 for Pfizer's Abrysvo. For adults aged 65 and older, the cost was lower at ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, and appointments, here’s a quick look at which stocks will be in focus in today ...

Given the large stake in the stock by institutions, GSK's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 25 shareholders Insiders have been ...